Free Trial

Synaptogenix (TAOX) Competitors

Synaptogenix logo
$8.36 +0.52 (+6.63%)
As of 04:00 PM Eastern

TAOX vs. ATYR, QNCX, CNTB, PLRX, IMMX, ORMP, CRDL, ADVM, BMEA, and SCLX

Should you be buying Synaptogenix stock or one of its competitors? The main competitors of Synaptogenix include aTyr Pharma (ATYR), Quince Therapeutics (QNCX), Connect Biopharma (CNTB), Pliant Therapeutics (PLRX), Immix Biopharma (IMMX), Oramed Pharmaceuticals (ORMP), Cardiol Therapeutics (CRDL), Adverum Biotechnologies (ADVM), Biomea Fusion (BMEA), and Scilex (SCLX). These companies are all part of the "pharmaceutical products" industry.

Synaptogenix vs. Its Competitors

aTyr Pharma (NASDAQ:ATYR) and Synaptogenix (NASDAQ:TAOX) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, earnings, profitability, analyst recommendations, risk, media sentiment, institutional ownership and valuation.

In the previous week, aTyr Pharma had 31 more articles in the media than Synaptogenix. MarketBeat recorded 33 mentions for aTyr Pharma and 2 mentions for Synaptogenix. Synaptogenix's average media sentiment score of 0.00 beat aTyr Pharma's score of -0.15 indicating that Synaptogenix is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
aTyr Pharma
0 Very Positive mention(s)
3 Positive mention(s)
27 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Neutral
Synaptogenix
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Synaptogenix has lower revenue, but higher earnings than aTyr Pharma. aTyr Pharma is trading at a lower price-to-earnings ratio than Synaptogenix, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
aTyr Pharma$230K414.46-$64.02M-$0.80-1.22
SynaptogenixN/AN/A-$12.77M-$20.16-0.41

61.7% of aTyr Pharma shares are held by institutional investors. Comparatively, 10.3% of Synaptogenix shares are held by institutional investors. 3.7% of aTyr Pharma shares are held by insiders. Comparatively, 2.7% of Synaptogenix shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

aTyr Pharma presently has a consensus target price of $23.25, indicating a potential upside of 2,290.01%. Given aTyr Pharma's stronger consensus rating and higher possible upside, research analysts plainly believe aTyr Pharma is more favorable than Synaptogenix.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
aTyr Pharma
1 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Synaptogenix
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

aTyr Pharma has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500. Comparatively, Synaptogenix has a beta of 1.89, indicating that its share price is 89% more volatile than the S&P 500.

aTyr Pharma's return on equity of -93.69% beat Synaptogenix's return on equity.

Company Net Margins Return on Equity Return on Assets
aTyr PharmaN/A -93.69% -68.83%
Synaptogenix N/A -277.76%-150.79%

Summary

aTyr Pharma beats Synaptogenix on 10 of the 14 factors compared between the two stocks.

Get Synaptogenix News Delivered to You Automatically

Sign up to receive the latest news and ratings for TAOX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TAOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TAOX vs. The Competition

MetricSynaptogenixPharmaceutical Preparations IndustryManufacturing SectorNASDAQ Exchange
Market Cap$27.36M$1.01B$2.53B$10.60B
Dividend YieldN/A4.84%2.49%4.86%
P/E Ratio-0.411.2221.8528.46
Price / SalesN/A29.59111.41128.87
Price / CashN/A17.6342.0260.64
Price / Book1.937.6933.246.53
Net Income-$12.77M-$7.91M$6.87M$276.75M
7 Day Performance8.01%-1.57%0.34%0.20%
1 Month Performance46.92%23.49%-0.27%1.67%
1 Year PerformanceN/A-14.91%95.09%32.73%

Synaptogenix Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TAOX
Synaptogenix
0.0649 of 5 stars
$8.36
+6.6%
N/AN/A$27.36MN/A-0.414Gap Up
ATYR
aTyr Pharma
2.8815 of 5 stars
$1.02
+2.0%
$23.25
+2,179.4%
-71.2%$99.95M$230K-1.2753Trending News
QNCX
Quince Therapeutics
2.7881 of 5 stars
$1.86
-3.6%
$8.14
+337.8%
+114.1%$99.91MN/A-1.7160
CNTB
Connect Biopharma
2.8245 of 5 stars
$1.73
-5.5%
$7.00
+304.6%
+27.5%$96.40M$26.03M0.00110
PLRX
Pliant Therapeutics
3.9819 of 5 stars
$1.57
-4.8%
$8.19
+421.5%
-87.6%$96.38M$1.58M-0.4690News Coverage
Options Volume
IMMX
Immix Biopharma
2.7097 of 5 stars
$2.87
+6.3%
$8.00
+178.7%
+87.3%$94.81MN/A-3.739
ORMP
Oramed Pharmaceuticals
0.2873 of 5 stars
$2.23
-1.8%
N/A-3.4%$91.44M$2M-6.3710News Coverage
CRDL
Cardiol Therapeutics
1.7929 of 5 stars
$1.03
-1.0%
$8.00
+676.7%
-36.4%$90.08MN/A-3.0320News Coverage
ADVM
Adverum Biotechnologies
3.5278 of 5 stars
$4.29
-5.9%
$19.75
+360.4%
-47.8%$90.02M$1M-0.55190
BMEA
Biomea Fusion
3.5361 of 5 stars
$1.51
-5.0%
$9.50
+529.1%
-87.4%$89.86MN/A-0.5050Gap Up
SCLX
Scilex
1.9274 of 5 stars
$12.78
-4.0%
$437.50
+3,323.3%
-61.2%$88.89M$56.59M-0.4480Gap Up

Related Companies and Tools


This page (NASDAQ:TAOX) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners